Illumine Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$552K Buy
600
+20
+3% +$20.3K 0.42% 73
2025
Q4
$623K Hold
580
0.45% 66
2025
Q3
$443K Buy
580
+30
+5% +$22.3K 0.32% 79
2025
Q2
$429K Hold
550
0.34% 77
2025
Q1
$454K Hold
550
0.37% 78
2024
Q4
$425K Buy
+550
New +$455K 0.35% 73

Other funds holding LLY

Illumine Investment Management's LLY Position: Q1 2026 in Review

Illumine Investment Management increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $20.3K and bringing the position to 600 shares worth $552K. The position accounts for 0.42% of the portfolio, ranked #73.

Illumine Investment Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $623K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Illumine Investment Management held 600 shares of Eli Lilly worth $552K as of Q1 2026.
  • Illumine Investment Management bought 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.42% of Illumine Investment Management's portfolio in Q1 2026, its #73 holding.
  • Illumine Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Illumine Investment Management's Eli Lilly position peaked at $623K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Illumine Investment Management's 13F filing for Q1 2026, filed 4 May 2026.